A new quantitative PCR for human parvovirus B19 genotypes

Area of Science:

• Virology
• Molecular Biology
• Infectious Diseases

Background:

• Parvovirus B19 (B19V) is a small ssDNA virus linked to diverse health issues, including erythema infectiosum and fetal mortality.
• Lifelong persistence of B19V genomes in host tissues necessitates accurate viral quantification for clinical management.
• Accurate B19V DNA quantification is crucial for determining primary infection timing, assessing tissue persistence, and screening blood donations.

Purpose of the Study:

• To develop and validate a novel quantitative PCR (qPCR) assay for the detection, quantification, and differentiation of all three Parvovirus B19 genotypes.
• To establish a sensitive and specific molecular tool for B19V analysis in various clinical specimens.

Main Methods:

• A new B19V-specific qPCR assay was designed targeting a 154-bp region within the NS1 gene.
• The assay was validated using the WHO International Reference Panel for Parvovirus B19 Genotypes.
• Serum, plasma, and solid tissue samples were tested for B19V detection and quantification.

Main Results:

• The developed qPCR assay demonstrated high specificity for B19V, detecting and quantifying all three genotypes.
• The assay achieved high sensitivity, with detection limits of ≤10 copies/reaction.
• Quantification results for panel members correlated well with established reference values from the NIBSC.
• Sanger sequencing was employed to confirm the differentiation of B19V genotypes.

Conclusions:

• The novel qPCR assay provides a reliable method for sensitive and specific detection, quantification, and genotyping of Parvovirus B19.
• This assay is suitable for analyzing diverse clinical samples, including serum, plasma, and solid tissues.
• The validated assay can be instrumental in clinical diagnostics, epidemiological studies, and blood screening for B19V.